Tramadol may cause awareness and EEG activation during anaesthesia. We compared tramadol with morphine, administered during wound-closure, surmising that tramadol may cause earlier awakening, more rapid recovery, less respiratory depression and equivalent pain relief. Forty patients received nitrous oxide-enflurane for abdominal surgery. At wound closure, patients received tramadol 3 mg kg 91 or morphine 0.2 mg kg 91 and end-tidal enflurane concentrations were maintained at 0.5 kPa until skin closure, whereupon anaesthesia was discontinued. Times to spontaneous respiration, awakening and orientation were similar in the two groups, as were blood-gas tensions, ventilatory frequency, pain scores and incidence of nausea. Half of each group required supplementary analgesia during their 90-min stay in the recovery room. P-deletion counts improved more rapidly in the tramadol group. This study confirms previous reports that tramadol did not antagonize the hypnotic effects of volatile anaesthetics. Tramadol, administered during operation, was as effective as morphine in providing postoperative analgesia while permitting more rapid psychomotor recovery. (Br.
Tramadol has been shown to increase the incidence of intraoperative awareness during nitrous oxide-oxygen anaesthesia. 1 Coetzee, Maritz and du Toit 2 showed that awareness is unlikely during light, stable anaesthesia with nitrous oxide and isoflurane. However, they demonstrated that tramadol caused dose-dependent activation of the electroencephalogram (EEG). Houmes and colleagues showed tramadol to be as effective and safe as morphine for the treatment of postoperative pain. 3 Potential advantages of administering tramadol for postoperative pain relief include long duration of action 4 and limited respiratory depressant effects. 3 5 Maximum analgesia occurs 1-2 h after i.v. administration, therefore tramadol should preferably be given during operation because administration after inhalation anaesthesia has been shown to provide inadequate postoperative pain relief. 4 6 In this study, we have compared the effects of tramadol or morphine administered during wound closure. The hypothesis was that tramadol would cause earlier awakening after anaesthesia, more rapid recovery of cognitive function, less respiratory depression during the immediate postoperative period and equivalent pain relief.
Patients and methods:
After obtaining approval from the Institutional Ethics Committee and informed consent, we studied 40 patients. ASA I or II, aged 23-67 yr, weighing 41-100 kg, in a comparative, double-blind, randomized study. Exclusion criteria were cardiac or pulmonary disease, pregnancy, lactation, administration of analgesic or psychotropic drugs, history of central nervous system disease (including epilepsy), history of a disabling psychiatric disorder and allergy to opioids. All patients underwent abdominal hysterectomy via a lower abdominal incision performed by various surgeons.
Postoperative pain intensity and cognitive function were assessed using a visual analogue scale (VAS) and a p-deletion test. In the latter test, the patient was presented with an A4 sheet containing 62 lines of 80 close-spaced, randomly typed, lower case letters per line and requested to delete as many letter p's as possible without omission, reading from left to right down the page. 7 8 All patients met the anaesthetist on the day before surgery who instructed them on how to use the VAS and p-deletion test. A baseline p-deletion score was obtained.
Patients were allocated randomly to one of two groups. Premedication and anaesthetic technique were the same in both groups. Premedication comprised diazepam 10 mg orally, administered 2 h before operation. Anaesthesia was induced with fentanyl 4 g kg 91 followed by propofol 1.5-2.0 mg kg 91 and vecuronium 0.08 mg kg
91
. The patient's trachea was intubated and ventilation was controlled using a circle-absorber breathing system to maintain endexpired carbon dioxide partial pressure at 4.0-4.5 kPa. Anaesthesia was maintained using enflurane and 60% nitrous oxide in oxygen. Enflurane concentrations were monitored using an infrared anaesthetic gas monitor (Siemens Sirecrust model 743G) and end-expired concentrations were maintained at 0. , measurements of arterial pressure and heart rate were documented before administering the drug and thereafter at 1, 5, 10 and 15 min after injection.
Also, at the start of wound closure, end-expired enflurane concentrations were decreased to 0.5% and ventilation minute volume reduced to allow endtidal carbon dioxide partial pressure to increase to 5.5 kPa. Residual neuromuscular block was antagonized with glycopyrrolate 0.008 mg kg 91 and neostigmine 0.03 mg kg
. At the last skin-stitch, the anaesthetic gases were discontinued and a fresh gas flow of 6 litre min 91 was administered. The trachea was extubated on awakening while breathing spontaneously after which patients were transported to the recovery area where they were monitored for at least 90 min.
Time to commencement of spontaneous respiration, time to awakening as judged by the patient responding to the command "open your eyes", and time to orientation (as judged by being able to respond correctly to the question "When is your birthday") were recorded in the operating room.
In the recovery area, all patients received 35% oxygen by mask. Pain intensity was assessed by the patient and anaesthetist on arrival in the recovery room and every 15 min thereafter using a visual analogue scale (0:no pain, 10:worst possible pain). In addition, the presence of nausea and/or vomiting was recorded and the success of antiemetic therapy noted. The extent of respiratory depression was assessed by measurement of arterial blood-gas tensions on arrival in the recovery room and by measuring ventilatory frequency every 15 min. Arterial blood was obtained by radial artery puncture into a heparinzed syringe, and a Stat Profile Ultra apparatus (Nova Biomedicals, MA, USA) was used to measure blood-gas partial pressures. Recovery of psychomotor function was assessed in the recovery room using the p-deletion test at 15-min intervals. Patients who requested additional pain relief were given morphine 0.15 mg kg 91 i.m. Nausea was treated with metoclopramide 10 mg i.v. Data were recorded for 90 min in the recovery area or until patients received additional analgesia.
DATA ANALYSIS
A 5-min time difference for regaining consciousness between groups was regarded as clinically significant (SD 5 min). Assuming an alpha value of 0.05, a sample size of 17 was calculated to be required for a power of 0.8 for the t test. Each individual's p-deletion tests were standardized by comparing with preoperative values and calculating the "speed" Statistical analysis was performed using a software package (Sigmastat for DOS version 5, Jandel Scientific Software, USA). Each patient's rate of recovery of cognitive function was assessed by determining the slope of the linear regression equation of p-deletion scores vs time. Inter-group comparisons were performed using unpaired two-tailed t tests. Pain scores were compared using the Mann-Whitney non-parametric test.
Results
Patient characteristics are presented in table 1. The two groups were comparable in age, weight, length and duration of anaesthesia. Tramadol 3 mg kg 91 or morphine 0.2 mg kg 91 administered during anaesthesia did not cause changes in arterial pressure or heart rate (table 2). In the operating room there were no differences in times to spontaneous respiration, awakening or orientation (table 3) .
On arrival in the recovery room, blood-gas tensions, ventilatory frequency and pain scores were similar in the two groups (table 4) . Ventilatory frequencies and pain scores remained similar in the two groups throughout the 90-min observation period (table 5) . Six patients in the tramadol group and eight patients in the morphine group required supplementary analgesia at 59 (SD 19) min and 69 (24) min, respectively (ns between groups) (table 4). Four and two patients suffered nausea in the tramadol and morphine groups, respectively (Fisher's exact test, P:0.42).
The baseline p-deletion counts were similar in the two groups (table 6) . No patient was able to perform p-deletion tests on arrival in the recovery room or 15 min thereafter. In both groups the number of capable 
Discussion
Patients were deliberately anaesthetized lightly (0.5% enflurane in 60% nitrous oxide) until the last skin stitch was applied in order to determine if tramadol would accelerate recovery from anaesthesia. In a previous study 2 we administered tramadol 100 mg and 200 mg during light isoflurane-nitrous oxide anaesthesia and found that tramadol caused significant dose-dependent activation of the EEG for at least 20 min, evidenced by increased EEG frequencies and decreased amplitudes. These changes were small and the derived EEG variables did not approach values known to be associated with near awakening during anaesthesia. In view of these facts, we surmised that a greater dose may generate sufficient arousal to hasten recovery from anaesthesia and we administered up to twice the largest dose of our previous study. This did not lead to more rapid emergence from anaesthesia or to earlier orientation. Therefore, our present findings support our previous conclusion that tramadol does not cause clinically significant lightening of anaesthesia. The significance of our previous finding of EEG activation by tramadol 2 is difficult to interpret. It is a well known phenomenon, however that certain hypnotics (e.g. midazolam, thiopental, etomidate) exhibit a biphasic response, causing EEG activation in low doses (in spite of subjects being sedated or even asleep) before leading to EEG depression. [9] [10] [11] [12] Duration of wound closure was similar in both groups so that it is unlikely that it could have had significant influence on postoperative measurements of recovery. Furthermore, administration of nitrous oxide and enflurane was continued up until the time of the last stitch in order to standardize the timing of the recovery process, thereby eliminating the influence of variation in the duration of wound closure. Tramadol or morphine was administered at the beginning of closure of the peritoneum, at which time end-expired enflurane concentrations were targeted at 0.5%. This was done for two reasons: first, as both morphine and tramadol are reputed to be somewhat slow-acting, we reasoned that at the end of wound closure, the drugs would be exerting maximum effects. Second, we normalized the recovery process by ensuring that the partial pressures of the anaesthetic gases were the same in all patients at the start of drug excretion. Additional evidence to support the conclusion that tramadol does not antagonize the hypnotic effects of anaesthetic gases is provided by the finding that for the first 15 min after arrival in the recovery room, all patients in both groups were unable to perform p-deletion tests. At 30 min only approximately 50% of patients in both groups were sufficiently alert to accomplish p-deletions. It is likely that during this early recovery phase, patients were encountering residual effects of enflurane and we suggest that if tramadol opposed the effects of the anaesthetic, the tramadol group would have performed better.
After 45 min in the recovery room, all patients in the tramadol and morphine groups were able to perform the p-deletion tests. From this time onwards, the tramadol patients had more rapid recovery of psychomotor function as evidenced by the greater slopes of their regression lines of p-deletions vs time and by their greater p-deletion counts and speed. This tendency towards more rapid recovery of psychomotor function is in agreement with the study of Vickers and colleagues 13 who compared tramadol with morphine for postoperative pain after abdominal surgery and found that there was a tendency to better recovery in those patients who received tramadol. This should not be interpreted as an indication that tramadol caused increased alertness, but rather that it caused less sedation than morphine.
Tramadol is reputed to cause less respiratory depression than morphine. 3 However, in our study, times to commencement of breathing in the operating room, blood-gas partial pressures on arrival in the recovery room and breathing rates were similar. Therefore, it appears that the two agents did not exert different effects on respiration after operation. This may perhaps be a result of the continuing depressant effects of enflurane masking any differences that may have existed in the the immediate postoperative period. It is possible that more sensitive tests of the respiratory centre (e.g. carbon dioxide dose-response curves) would have detected a minor difference, however, the difference is not likely to have been clinically relevant. Pulse oximetry was not used as a measure of respiratory depression because all patients were breathing high oxygen concentrations and would have most likely remained well oxygenated in spite of moderate hypoventilation. Our tramadol dose of 3 mg kg 91 was higher than previously recommended doses for pain relief after abdominal surgery. There is considerable variation in the doses that have been found to be effective in previous studies. Houmes and colleagues 3 administered a maximum of 150 mg in three divided doses over 6 h and found this to be insufficient for patients experiencing severe pain. Vickers and colleagues 13 administered greater doses; an initial dose of 100 mg followed by a flexible dosing regimen, providing up to 100-250 mg in the first 90 min and 650 mg during the first 24 h. The initial bolus provided sufficient pain relief in only 12.5% of patients and the overall responder rate was only 72.6%. During the first 1.5 h, patients required 188.2 mg. The authors concluded that adequate dosing in the early postoperative phase is important and that relief of pain after abdominal surgery is indistinguishable from that of morphine if given in appropriate i.v. doses. Therefore, we suggest that the greater tramadol dose (3 mg kg
91
) that we used is more suitable for treatment of postoperative pain, causing minimal side effects.
Tramadol, a weak mu-agonist, has not been shown to potentiate the effects of anaesthetics and therefore it is generally not recommended as an adjunct to anaesthetic agents during surgery. It is our practice, however, to administer analgesics during the final stages of a surgical procedure to ensure that patients have basic pain relief during the immediate postoperative phase. Used in this way at a dose of 3 mg kg 91 , our study indicated that tramadol was as effective as morphine for controlling pain in the immediate postoperative period, without any increase in the incidence of nausea and vomiting or cardiovascular changes. Furthermore, there was a more rapid rate of recovery of psychomotor function probably caused by the lack of significant sedating effects. We suggest therefore that tramadol has a useful role in anaesthetic practice, particularly for day-surgery where rapid return to normal activities is desired.
